Patent · US Active

Neuroprotective quinoline sulfonamides

US11213701B2 · kind B2 · utility

0Cited by
0References
4Claims
0Family size

Inventor

Key dates

Filing dateDec 1, 2019
Grant dateJan 4, 2022
Priority date—
Expiry dateDec 1, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods and compositions comprising compounds capable of activating and increasing protein SUMOylation. Disclosed herein are methods and compositions comprising compounds capable of showing neuroprotective and cytoprotective effects when administered to injured cells. Also disclosed are methods comprising these compounds for treating neuronal or neurological disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, fronto-temporal dementia, chronic traumatic encepholopathy, traumatic brain injury, or stroke.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.